Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE).
about
Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell BiologyUtilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy DeliveryInteractions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and CancerGlycosaminoglycan-functionalized poly-lactide-co-glycolide nanoparticles: synthesis, characterization, cytocompatibility, and cellular uptakeHomodimerization of the Lymph Vessel Endothelial Receptor LYVE-1 through a Redox-labile Disulfide Is Critical for Hyaluronan Binding in Lymphatic EndotheliumHyaluronan expressed by the hematopoietic microenvironment is required for bone marrow hematopoiesis.Growth factor PDGF-BB stimulates cultured cardiomyocytes to synthesize the extracellular matrix component hyaluronan.Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes.N-Glycans on the link domain of human HARE/Stabilin-2 are needed for hyaluronan binding to purified ecto-domain, but not for cellular endocytosis of hyaluronanAging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression.Hyaluronan as an immune regulator in human diseases.Tissue-specific splice variants of HARE/Stabilin-2 are expressed in bone marrow, lymph node, and spleen.Hyaluronic acid receptor Stabilin-2 regulates Erk phosphorylation and arterial--venous differentiation in zebrafish.HARE-Mediated Endocytosis of Hyaluronan and Heparin Is Targeted by Different Subsets of Three Endocytic Motifs.Activation of ERK and NF-κB during HARE-Mediated Heparin Uptake Require Only One of the Four Endocytic Motifs.Probing structural selectivity of synthetic heparin binding to Stabilin protein receptorsApoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor.Hyaluronan as a therapeutic target in human diseasesStabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver.The hyaluronan receptor for endocytosis (HARE) activates NF-κB-mediated gene expression in response to 40-400-kDa, but not smaller or larger, hyaluronans.The ligand-binding profile of HARE: hyaluronan and chondroitin sulfates A, C, and D bind to overlapping sites distinct from the sites for heparin, acetylated low-density lipoprotein, dermatan sulfate, and CS-E.Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.The potential of chondroitin sulfate as a therapeutic agent.Rat and human HARE/stabilin-2 are clearance receptors for high- and low-molecular-weight heparins.Hyaluronic acid receptor for endocytosis (HARE)-mediated endocytosis of hyaluronan, heparin, dermatan sulfate, and acetylated low density lipoprotein (AcLDL), but not chondroitin sulfate types A, C, D, or E, activates NF-κB-regulated gene expressionThe crosstalk of hyaluronan-based extracellular matrix and synapses.Role of phosphatidylserine receptors in enveloped virus infection.Nanostructured hyaluronic acid-based materials for active delivery to cancer.Antisense Oligonucleotides: Treatment Strategies and Cellular Internalization.Hyaluronan metabolism in remodeling extracellular matrix: probes for imaging and therapy of breast cancer.Biology and biotechnology of hyaluronan.Catabolism of chondroitin sulfate.The hyaluronan receptor for endocytosis mediates hyaluronan-dependent signal transduction via extracellular signal-regulated kinases.Unbinding of hyaluronan accelerates the enzymatic activity of bee hyaluronidase.Lipid-based nanosystems for CD44 targeting in cancer treatment: recent significant advances, ongoing challenges and unmet needs.The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparinCross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft model.In vivo liver endocytosis followed by purification of liver cells by liver perfusion.The cytoplasmic domain of the hyaluronan receptor for endocytosis (HARE) contains multiple endocytic motifs targeting coated pit-mediated internalizationMolecular control of the hyaluronan biosynthesis.
P2860
Q26786063-88DBDF63-D6E8-4751-8EA9-99E20AFA6D5EQ26786070-A080AE52-7F0E-4996-B72E-E51594A24179Q27021261-85C31DED-04EE-41FA-B2ED-AD643BDAB020Q28386409-08C8CF9B-0CED-4AE4-91B8-63D99D2712BFQ28593262-49DD569A-81F3-467B-A8CA-B1C816A7DF11Q30523754-D287C3C4-B159-41B5-ADE7-07D8A7CFB544Q33784184-48344EE6-0D1E-47DB-960B-632BEE936DEFQ33811463-EC179ED1-A21B-45D1-99CD-E55FF3B00695Q33955772-61054CC0-B670-4AD0-BB33-3FF43FB9C447Q34507732-65DE74CE-0F32-4215-BC8E-82DC11476BF1Q34636380-A2FE5F19-11D2-43B5-AE50-32D9AC2AF08DQ34772053-6153E27C-E705-49DF-A41D-98FDE43C50E7Q35106180-7C260202-9DF8-4974-8BD9-4DA397C8A873Q35324915-EAC33942-5DBE-4375-AA6C-1AE83E890A46Q35995906-A09D44E6-DBB1-48B9-BC5F-B6FA4D69018EQ36033096-0263EE36-1C5C-42D8-AE5C-979AB92A5401Q36131729-AAB40AEE-EE1F-4AA6-8D66-15B29D79A121Q36578627-19F253B6-B990-4722-803B-F5A040BDCE6FQ36775577-6A138BAF-BE4A-41B3-A227-1C005A00410EQ36850223-DD6E63C7-165D-417A-A680-A82F6B0FD9D4Q36922376-05201121-915A-4AD5-A48A-333ECEEC9D61Q37188974-5738DC4D-64AF-484D-98C8-F59CFFDA1FB1Q37228620-98EB0365-A900-4C46-A0B9-DE60C97E98E2Q37231336-C7E3D323-6267-4B20-A70F-D992FF82DD62Q37488558-1F88152B-CD4A-4BC6-87AC-62698B407A1CQ37610538-C4D429F8-334A-4952-A8C3-885D3A786BD1Q37713918-A900C991-182A-42C3-BFF5-3047B0865D8EQ37724371-D14ADC10-28A5-4E8D-B358-12F3E723BF0EQ37733136-E5D9DF19-E1DD-40AA-A683-E9F8ED603879Q37832163-167878B2-B908-41A6-86E5-19B515F0653BQ38478146-CFF2D143-045A-492D-837F-B75AAFBAF045Q38552797-7C6D71D3-E01D-438E-A2AC-1EB5807A0241Q38631638-3BABDA50-3F70-4F42-B772-333C008354F8Q38734533-D0613FDF-6457-44A7-8AF1-953DBF0A8C80Q38889576-065CA091-0369-45E4-A5E3-499DB7334795Q39143125-5E6C8C8A-6265-4C1E-88AD-17CC22DD5B0EQ39183455-226D3531-B59F-441A-991F-AEA1894E3DF3Q39439294-7C3BAF3A-2C6D-4CC1-AC93-9B8ADC576D21Q41177184-AFB9D4ED-5EE9-49C0-887A-8442041B85A6Q46459770-8C1BE6F7-B25A-4544-8B02-07C197F54D65
P2860
Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE).
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Expression, processing, and gl ...... ceptor for endocytosis (HARE).
@ast
Expression, processing, and gl ...... ceptor for endocytosis (HARE).
@en
Expression, processing, and gl ...... ceptor for endocytosis (HARE).
@nl
type
label
Expression, processing, and gl ...... ceptor for endocytosis (HARE).
@ast
Expression, processing, and gl ...... ceptor for endocytosis (HARE).
@en
Expression, processing, and gl ...... ceptor for endocytosis (HARE).
@nl
prefLabel
Expression, processing, and gl ...... ceptor for endocytosis (HARE).
@ast
Expression, processing, and gl ...... ceptor for endocytosis (HARE).
@en
Expression, processing, and gl ...... ceptor for endocytosis (HARE).
@nl
P2093
P2860
P356
P1476
Expression, processing, and gl ...... ceptor for endocytosis (HARE).
@en
P2093
Edward N Harris
Janet A Weigel
Paul H Weigel
Svetlana V Kyosseva
P2860
P304
P356
10.1074/JBC.M607787200
P407
P577
2006-12-04T00:00:00Z